Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $76 at BMO Capital Following 1Q

May 3, 2017 9:17 AM
BMO Capital raised its price target on Gilead Sciences (NASDAQ: GILD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles